Result of AGM
Futura Medical plc announced that all resolutions were passed at its Annual General Meeting, with strong shareholder support for the adoption of the 2025 annual report and accounts (99.07% for), the re-election of Jeff Needham (98.62% for), the appointment of Alex Duggan (97.11% for), the re-appointment of auditors Grant Thornton UK LLP (99.01% for), and the authorisation of director remuneration for auditors (97.60% for). Shareholders also approved the general authority for directors to allot shares (95.47% for) and the disapplication of pre-emption rights for an additional 20% of issued share capital (93.94% for), along with the allotment of equity securities for cash under that authority (95.20% for).
Select text to share a quote on X · sign in to keep highlights & notes in your FUM notes
Futura Medical plc (AIM: FUM), the consumer healthcare Group behind Eroxon®, that specialises in the development and global commercialisation of innovative and clinically proven sexual health products, today announces that at its Annual General Meeting, held today at 10:00am BST, the shareholders duly passed all resolutions.
The total number of votes received on each resolution were as follows:
| Voting For | Voting Against | |||||||
|---|---|---|---|---|---|---|---|---|
| Number of votes i | % | Number of votes | % | Total Votes | % ISC | Votes withheld ii | ||
| Resolution 1 | To receive and adopt the annual report and accounts for the financial year ended 31 December 2025 | 45,026,525 | 99.07 | 424,498 | 0.93 | 45,451,023 | 7.82 | 723,930 |
| Resolution 2 | To re-elect Jeff Needham as a Director of the Company, who retires by rotation in accordance with the Company's articles of association | 45,096,432 | 98.62 | 633,121 | 1.38 | 45,729,553 | 7.87 | 445,400 |
| Resolution 3 | That Alex Duggan be and is hereby appointed as a Director of the Company. | 44,241,310 | 97.11 | 1,168,069 | 2.89 | 40,409,379 | 6.95 | 765,574 |
| Resolution 4 | To re-appoint Grant Thornton UK LLP as auditor of the Company to hold office until the conclusion of the next annual general meeting of the Company. | 44,883,985 | 99.01 | 447,897 | 0.99 | 45,331,882 | 7.80 | 843,071 |
| Resolution 5 | To authorise the Directors to determine the remuneration of Grant Thornton UK LLP as auditor of the Company. | 44,230,302 | 97.60 | 1,086,465 | 2.40 | 45,316,767 | 7.80 | 858,186 |
| Resolution 6 | That the Directors be and are generally and unconditionally authorised for the purposes of section 551 Companies Act 2006 to exercise all the powers of the Company to allot shares in the Company and to grant rights to subscribe for or to convert any security into shares in the Company | 42,621,931 | 95.47 | 2,024,035 | 5.53 | 44,645,966 | 7.68 | 1,528,987 |
| Resolution 7 iii | Disapplication of pre-emption rights in respect of an additional 20% of the company issued share capital | 41,837,465 | 93.94 | 2,698,884 | 6.06 | 44,536,349 | 7.66 | 1,638,604 |
| Resolution 8 iii | To resolve that, subject to the passing of Resolution 7 set out above, the Directors be authorised in addition to any authority granted under Resolution 8 to allot equity securities for cash under the authority given by that resolution as if section 561 of the CA 2006 did not apply to any such allotment or sale | 42,503,811 | 95.20 | 2,144,255 | 4.80 | 44,648,066 | 7.68 | 1,526,887 |
i Where shareholders appointed the Chairman as their proxy with discretion as to voting, their votes were cast in favour of the resolution
ii A vote withheld is not a vote in law and is not counted towards the votes cast "For" or "Against" a resolution
iii ⁱSpecial Resolution (75% majority required)
The total voting rights of the Company as at 10:00 am on 25 June 2026 (the time by which shareholders wanting to vote at the AGM were required to be entered on the register) was 581,327,755 ordinary shares of 0.2 pence each. The Company does not hold any shares in treasury.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.